American Heart Journal
Volume 157, Issue 5 , Pages e35-e37 , May 2009

Treating depression in patients with heart disease: Is the glass half empty or half full?

References 

  1. Romanoski AJ, Folstein MF, Nestadt G. The epidemiology of psychiatrist-ascertained depression and DSM-III depressive disorders: results from the Eastern Baltimore Mental Health Survey Clinical Reappraisal. Psychol Med. 1992;22:629–655
  2. Blazer DG, Landerman LR, Hays JC, et al. Symptoms of depression among community-dwelling elderly African American and white older adults. Psychol Med. 1998;22:1311–1320
  3. Blazer DG, Hybels CF, Simonsick EM. Marked differences in antidepressant use by race in an elderly community sample: 1986-1996. Am J Psychiatry. 2000;157:1089–1094
  4. Skaer TL, Sclar DA, Robison LM, et al. Trends in the rate of depressive illness and use of antidepressant pharmacotherapy by ethnicity/race: an assessment of office-based visits in the United States, 1992-1997. Clin Ther. 2000;22:1575–1589
  5. Sclar DA, Robison LM, Skaer TL. Ethnicity/race and the diagnosis of depression and use of antidepressants by adults in the United States. Int Clin Psychopharmacol. 2008;23:106–109
  6. Harman JS, Edlund MJ, Fortney JC. Disparities in the adequacy of depression treatment in the United States. Psychiatr Serv. 2004;55:1379–1385
  7. Strothers HS, Rust G, Minor P, et al. Disparities in antidepressant treatment in Medicaid elderly diagnosed with depression. J Am Geriatr Soc. 2005;53:456–461
  8. Babyak M. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med. 2004;66:411–421
  9. Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165:710–718
  10. Harrell FE. Regression modeling strategies. NY: Springer; 2001;
  11. Carney RM, Blumenthal JA, Freedland KE, et al. Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med. 2004;66:466–474
  12. Ray WA, Hall K, Meador KG. Racial differences in antidepressant treatment preceding suicide in a Medicaid population. Psychiatr Serv. 2007;58:1317–1323
  13. Schnittker J. Misgivings of medicine?: African Americans skepticism of psychiatric medication. J Health Soc Behav. 2003;44:506–524
  14. Alegria M, Chatterji P, Wells K, et al. Disparity in depression treatment among racial and ethnic minority populations in the United States. Psychiatr Serv. 2008;59:1264–1272
  15. Thombs BD, De Jonge P, Coyne JC, et al. Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA. 2008;300:2161–2171
  16. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation. 1995;91:999–1005
  17. Jiang W, Alexander J, Christopher E, et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med. 2001;161:1849–1856
  18. Sherwood A, Blumenthal JA, Trivedi R, et al. Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med. 2007;167:367–373
  19. Blumenthal JA, Lett HS, Babyak MA, et al. Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet. 2003;362:604–609
  20. Berkman L, Blumenthal JA, Burg MM, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA. 2003;289:3106–3116
  21. Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288:701–709
  22. Lesperance F, Frasure-Smith N, Koszycki D, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease. JAMA. 2007;297:367–379
  23. Taylor CB, Youngblood ME, Catellier D, et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry. 2005;62:792–798
  24. Blumenthal JA, Babyak M, Moore KA, et al. Effects of exercise training on older patients with major depression. Arch Intern Med. 1999;159:2349–2356
  25. Blumenthal JA, Babyak MA, Doraiswamy MP, et al. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med. 2007;69:587–596
  26. Whooley MA, De Jonge P, Vittinghoff E, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA. 2008;300:2379–2388
  27. Blumenthal JA, Sherwood A, Rogers SD, et al. Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study—rationale, design, and methodological issues. Clin Trials. 2007;4:548–559

PII: S0002-8703(09)00161-6

doi: 10.1016/j.ahj.2009.03.006

American Heart Journal
Volume 157, Issue 5 , Pages e35-e37 , May 2009

Article Tools